Drugmaker readies possible coronavirus vaccine for testing
Massachusett, Feb 25 (AP) Drugmaker Moderna has shipped its first batch of a possible coronavirus vaccine for humans to government researchers for testing. Shares of the biotech company soared early Tuesday, a day after the company said it sent vials to the National Institute of Allergy and Infectious Diseases for early-stage testing in the United States.
More than 80,000 people have been infected globally from the viral outbreak that began late last year in China. A total of 35 cases have been reported in the United States. More than 2,600 people have died from the virus in mainland China, including one US citizen.
Shares of Cambridge, Massachusetts-based Moderna Inc. jumped nearly 16 per cent, or USD 2.92, to USD 21.51 in premarket trading. The stock started trading in late 2018 and set an all-time high price of $29.79 last April, according to FactSet. (AP)
NSA
ALSO READ
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
WHO Brings Global Experts Together to Strengthen Herbal Medicine Quality and Safety
-
Human Cost of Faster Work: Chinese Employees Weigh AI’s Promise Against Pay Fears
-
Iran’s Civilians Trapped Between State Repression and Deadly Strikes, UN Warns
-
China's August Disasters Yield $5.38 Billion in Losses
Google News